Variant report
Variant | nsv518640 |
---|---|
Chromosome Location | chr13:62671507-62680229 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188671 | chr13:62671507-62671508 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs11840091 | chr13:62671569-62671570 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs563992128 | chr13:62671591-62671592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182328662 | chr13:62672218-62672219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1505532 | chr13:62672225-62672226 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs147194079 | chr13:62672228-62672229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541965078 | chr13:62672238-62672239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188072334 | chr13:62672258-62672259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369788639 | chr13:62672284-62672285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140400114 | chr13:62672296-62672297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs149704406 | chr13:62672373-62672374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571197980 | chr13:62672386-62672387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs559570639 | chr13:62674404-62674405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532808610 | chr13:62674411-62674412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs73222846 | chr13:62674419-62674420 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs181332520 | chr13:62674442-62674443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73222847 | chr13:62674450-62674451 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs548777896 | chr13:62674468-62674469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs167434 | chr13:62674473-62674474 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs528255813 | chr13:62674480-62674481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546921492 | chr13:62674501-62674502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571563348 | chr13:62674530-62674531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539875044 | chr13:62674539-62674540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529279053 | chr13:62674544-62674545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs569922770 | chr13:62674574-62674575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184280 | chr13:62674584-62674585 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs11618499 | chr13:62674590-62674591 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs573895979 | chr13:62674609-62674610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs146861099 | chr13:62674637-62674638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185223539 | chr13:62674664-62674665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150718476 | chr13:62674687-62674688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs80121040 | chr13:62674716-62674717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140493162 | chr13:62674749-62674750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548234734 | chr13:62674807-62674808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs575097389 | chr13:62674823-62674824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs117443482 | chr13:62674848-62674849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189253731 | chr13:62674885-62674886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571809728 | chr13:62674900-62674901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73505018 | chr13:62674910-62674911 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs563810066 | chr13:62674934-62674935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546801000 | chr13:62674951-62674952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs308686 | chr13:62675044-62675045 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs532470197 | chr13:62675080-62675081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs186300057 | chr13:62675136-62675137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs36101810 | chr13:62675143-62675144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570039305 | chr13:62675186-62675187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs367971203 | chr13:62675191-62675192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11618767 | chr13:62675225-62675226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150438188 | chr13:62675230-62675231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs73505023 | chr13:62675264-62675265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:62671400-62671600 | Enhancers | Adipose Nuclei | Adipose |
2 | chr13:62672200-62672400 | Enhancers | Adipose Nuclei | Adipose |
3 | chr13:62674400-62674600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr13:62674600-62689400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |